BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 26775086)

  • 1. Entamoeba thiol-based redox metabolism: A potential target for drug development.
    Jeelani G; Nozaki T
    Mol Biochem Parasitol; 2016; 206(1-2):39-45. PubMed ID: 26775086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase.
    Leitsch D; Kolarich D; Wilson IB; Altmann F; Duchêne M
    PLoS Biol; 2007 Aug; 5(8):e211. PubMed ID: 17676992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entamoeba histolytica: identification of thioredoxin-targeted proteins and analysis of serine acetyltransferase-1 as a prototype example.
    Schlosser S; Leitsch D; Duchêne M
    Biochem J; 2013 Apr; 451(2):277-88. PubMed ID: 23398389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Antiamebic Compounds That Inhibit Cysteine Synthase From the Enteric Parasitic Protist
    Mori M; Tsuge S; Fukasawa W; Jeelani G; Nakada-Tsukui K; Nonaka K; Matsumoto A; Ōmura S; Nozaki T; Shiomi K
    Front Cell Infect Microbiol; 2018; 8():409. PubMed ID: 30568921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin-linked metabolism in Entamoeba histolytica.
    Arias DG; Gutierrez CE; Iglesias AA; Guerrero SA
    Free Radic Biol Med; 2007 May; 42(10):1496-505. PubMed ID: 17448896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action.
    Parsonage D; Sheng F; Hirata K; Debnath A; McKerrow JH; Reed SL; Abagyan R; Poole LB; Podust LM
    J Struct Biol; 2016 May; 194(2):180-90. PubMed ID: 26876147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global analysis of gene expression in response to L-Cysteine deprivation in the anaerobic protozoan parasite Entamoeba histolytica.
    Husain A; Jeelani G; Sato D; Nozaki T
    BMC Genomics; 2011 May; 12():275. PubMed ID: 21627801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New enzymatic pathways for the reduction of reactive oxygen species in Entamoeba histolytica.
    Cabeza MS; Guerrero SA; Iglesias AA; Arias DG
    Biochim Biophys Acta; 2015 Jun; 1850(6):1233-44. PubMed ID: 25725270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric analysis of L-cysteine metabolism: physiological role and fate of L-cysteine in the enteric protozoan parasite Entamoeba histolytica.
    Jeelani G; Sato D; Soga T; Watanabe H; Nozaki T
    mBio; 2014 Nov; 5(6):e01995. PubMed ID: 25370494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entamoeba histolytica: response of the parasite to metronidazole challenge on the levels of mRNA and protein expression.
    Tazreiter M; Leitsch D; Hatzenbichler E; Mair-Scorpio GE; Steinborn R; Schreiber M; Duchêne M
    Exp Parasitol; 2008 Dec; 120(4):403-10. PubMed ID: 18845147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli mediated resistance of Entamoeba histolytica to oxidative stress is triggered by oxaloacetate.
    Shaulov Y; Shimokawa C; Trebicz-Geffen M; Nagaraja S; Methling K; Lalk M; Weiss-Cerem L; Lamm AT; Hisaeda H; Ankri S
    PLoS Pathog; 2018 Oct; 14(10):e1007295. PubMed ID: 30308066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two atypical L-cysteine-regulated NADPH-dependent oxidoreductases involved in redox maintenance, L-cystine and iron reduction, and metronidazole activation in the enteric protozoan Entamoeba histolytica.
    Jeelani G; Husain A; Sato D; Ali V; Suematsu M; Soga T; Nozaki T
    J Biol Chem; 2010 Aug; 285(35):26889-26899. PubMed ID: 20592025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug targets and mechanisms of resistance in the anaerobic protozoa.
    Upcroft P; Upcroft JA
    Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum.
    Müller S
    Mol Microbiol; 2004 Sep; 53(5):1291-305. PubMed ID: 15387810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EhMLBP is an essential constituent of the Entamoeba histolytica epigenetic machinery and a potential drug target.
    Lavi T; Siman-Tov R; Ankri S
    Mol Microbiol; 2008 Jul; 69(1):55-66. PubMed ID: 18484949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase.
    Wassmann C; Hellberg A; Tannich E; Bruchhaus I
    J Biol Chem; 1999 Sep; 274(37):26051-6. PubMed ID: 10473552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional thioredoxin reductase from pathogenic and free-living Leptospira spp.
    Sasoni N; Iglesias AA; Guerrero SA; Arias DG
    Free Radic Biol Med; 2016 Aug; 97():1-13. PubMed ID: 27178006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalization and enzymatic functional characterization of the thioredoxin system in Entamoeba histolytica.
    Arias DG; Carranza PG; Lujan HD; Iglesias AA; Guerrero SA
    Free Radic Biol Med; 2008 Jul; 45(1):32-9. PubMed ID: 18394433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entamoeba histolytica thioredoxin reductase: molecular and functional characterization of its atypical properties.
    Arias DG; Regner EL; Iglesias AA; Guerrero SA
    Biochim Biophys Acta; 2012 Dec; 1820(12):1859-66. PubMed ID: 22967759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabeprazole inhibits several functions of Entamoeba histolytica related with its virulence.
    Martínez-Pérez Y; Nequiz-Avendaño M; García-Torres I; Gudiño-Zayas ME; López-Velázquez G; Enríquez-Flores S; Mendoza E; Saavedra E; Pérez-Tamayo R; León-Avila G; Olivos-García A
    Parasitol Res; 2020 Oct; 119(10):3491-3502. PubMed ID: 32886229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.